Diaz-Manera J - Search Results

1

Comparison of dysferlin expression in human skeletal muscle with that in monocytes for the diagnosis of dysferlin myopathy.

Gallardo E, de Luna N, Diaz-Manera J, Rojas-García R, Gonzalez-Quereda L, Flix B, de Morrée A, van der Maarel S, Illa I. Gallardo E, et al. PLoS One. 2011;6(12):e29061. doi: 10.1371/journal.pone.0029061. Epub 2011 Dec 16. PLoS One. 2011. PMID: 22194990 Free PMC article.

2

["Seronegative" myasthenia gravis and antiMuSK positive antibodies: description of Spanish series].

Illa I, Díaz-Manera JA, Juárez C, Rojas-García R, Molina-Porcel L, Aleu A, Pradas J, Gallardo E. Illa I, et al. Med Clin (Barc). 2005 Jun 18;125(3):100-2. doi: 10.1157/13076937. Med Clin (Barc). 2005. PMID: 15989843 Spanish.

3

A novel antiganglioside specificity against terminal NeuNAc(alfa 2-3)Gal in acute bulbar palsy.

Rojas-Garcia R, Martinez-Lage M, Gallardo E, de Luna N, Marti-Vilalta JL, Diaz-Manera J, Juarez C, Blesa R, Illa I. Rojas-Garcia R, et al. J Neuroimmunol. 2006 Jul;176(1-2):219-22. doi: 10.1016/j.jneuroim.2006.04.001. Epub 2006 May 16. J Neuroimmunol. 2006. PMID: 16707165

4

Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.

Díaz-Manera J, Rojas-García R, Gallardo E, Juárez C, Martínez-Domeño A, Martínez-Ramírez S, Dalmau J, Blesa R, Illa I. Díaz-Manera J, et al. Nat Clin Pract Neurol. 2007 Jul;3(7):405-10. doi: 10.1038/ncpneuro0526. Nat Clin Pract Neurol. 2007. PMID: 17611489

5

Antibodies against disialosyl and terminal NeuNAc(alpha2-3)Gal ganglioside epitopes in acute relapsing sensory ataxic neuropathy.

Rojas-Garcia R, Gallardo E, Povedano M, de Luna N, Bruna J, Juarez C, Diaz-Manera J, Martinez-Matos JA, Illa I. Rojas-Garcia R, et al. J Neurol. 2008 May;255(5):764-6. doi: 10.1007/s00415-008-0803-0. Epub 2008 Mar 17. J Neurol. 2008. PMID: 18344054 No abstract available.

6

Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients.

Illa I, Diaz-Manera J, Rojas-Garcia R, Pradas J, Rey A, Blesa R, Juarez C, Gallardo E. Illa I, et al. J Neuroimmunol. 2008 Sep 15;201-202:90-4. doi: 10.1016/j.jneuroim.2008.04.039. Epub 2008 Jul 23. J Neuroimmunol. 2008. PMID: 18653247

7

Response to methotrexate in a chronic inflammatory demyelinating polyradiculoneuropathy patient.

Díaz-Manera J, Rojas-García R, Gallardo E, Illa I. Díaz-Manera J, et al. Muscle Nerve. 2009 Mar;39(3):386-8. doi: 10.1002/mus.21171. Muscle Nerve. 2009. PMID: 19208395

8

Treatment strategies for myasthenia gravis.

Díaz-Manera J, Rojas-García R, Illa I. Díaz-Manera J, et al. Expert Opin Pharmacother. 2009 Jun;10(8):1329-42. doi: 10.1517/14656560902950619. Expert Opin Pharmacother. 2009. PMID: 19445561 Review.

9

Treatment strategies for myasthenia gravis: an update.

Díaz-Manera J, Rojas García R, Illa I. Díaz-Manera J, et al. Expert Opin Pharmacother. 2012 Sep;13(13):1873-83. doi: 10.1517/14656566.2012.705831. Epub 2012 Jul 9. Expert Opin Pharmacother. 2012. PMID: 22775575 Review.

10

The increase of pericyte population in human neuromuscular disorders supports their role in muscle regeneration in vivo.

Díaz-Manera J, Gallardo E, de Luna N, Navas M, Soria L, Garibaldi M, Rojas-García R, Tonlorenzi R, Cossu G, Illa I. Díaz-Manera J, et al. J Pathol. 2012 Dec;228(4):544-53. doi: 10.1002/path.4083. Epub 2012 Oct 5. J Pathol. 2012. PMID: 22847756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters